BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1969311)

  • 1. Autologous blood stem cell transplantation in hematological malignancies. The Italian experience. Italian Cooperative Study Group.
    Iacone A; Dragani A; Fioritoni G; Quaglietta A; D'Antonio D; Montuoro A; De Rosa L; Scimè R; Majolino I; Menichella G
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():46-7. PubMed ID: 1969311
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral blood stem cell (PBSC) autograft in the treatment of high-risk leukemia/lymphoma of children. Children's PBSC Autografts Study Group of Japan.
    Takaue Y; Kawano Y; Watanabe T; Abe T; Hirose M; Kuroda Y; Ninomiya T; Yokobayashi A; Matsushita T; Uchiyama H
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():50. PubMed ID: 1969313
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
    Ke X; Yang Y; Zhao X; Wang L
    Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution.
    Rogulj D; Batinić D; Nemet D; Petrovecki M
    Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematopoietic stem cell transplantation for hematological malignancies].
    Zhong MZ; Chen FP; Shu YG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):242-4. PubMed ID: 12575304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collection of blood stem cells and therapeutic applications].
    Reiffers J; Boiron JM; Marit G; Bouzgarrou R; Bernard P; David B; Foures C; Broustet A; Vezon G
    Ann Med Interne (Paris); 1988; 139 Suppl 1():3-6. PubMed ID: 2907850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
    Suzue T; Takaue Y; Watanabe A; Kawano Y; Watanabe T; Abe T; Kuroda Y; Matsushita T; Kikuta A; Iwai A
    Exp Hematol; 1994 Nov; 22(12):1197-202. PubMed ID: 7523170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow/stem cell transplantation: initial experience at a north Indian referral centre.
    Gupta S; Kumar L; Raju GM; Kochupillai V; Shukla DK
    Natl Med J India; 2000; 13(2):61-6. PubMed ID: 10835851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eight years of experience in a single institution in hematopoietic stem cell autologous transplantation in malignant hematological diseases and in solid tumors].
    Milone GA; Martínez Rolón J; Fernández II; Corrado CS; Desmery PM; Dignani MC; Juni M; Pavlovsky S
    Medicina (B Aires); 2000; 60(1):115-24. PubMed ID: 10835708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
    Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S
    Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous blood stem cell transplantation as intensive consolidation therapy in hematological malignancies.
    Fioritoni G; Iacone A; D'Antonio D; Dragani A; Quaglietta AM; Accorsi P; Angelini A; Spadano A; Natale D; Berardi A
    Haematologica; 1990; 75 Suppl 1():60-4. PubMed ID: 1972130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Yamane T; Ohta T; Kou KR; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Gan To Kagaku Ryoho; 1994 May; 21(6):903-6. PubMed ID: 7910450
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonmyeloablative allogeneic stem cell transplantation in elder patients with hematological malignancies].
    Yoshida T
    Rinsho Ketsueki; 2004 Feb; 45(2):132-8. PubMed ID: 15045821
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM; Honegger HP; Stahel RA
    Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose chemotherapy with peripheral blood stem cell (PBSC) support in solid tumours: preliminary results.
    Martín Algarra S; Sureda M; Rebollo J; Henríquez I; Subirá ML
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():60-1. PubMed ID: 1969319
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches to blood stem cell mobilisation. Initial Australian clinical results.
    Juttner CA; To LB; Haylock DN; Dyson PG; Bradstock KF; Dale BM; Enno A; Sage RE; Szer J; Toogood IR
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():22-4. PubMed ID: 1969302
    [No Abstract]   [Full Text] [Related]  

  • 18. Autologous blood stem cell grafting in hematological malignancies. Present status and future directions.
    Reiffers J; Marit G; Vezon G; Cony-Makhoul P; Boiron JM; Montastruc M; Rice A; Broustet A
    Transfus Sci; 1992; 13(4):399-405. PubMed ID: 10147738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients].
    Medinger P; Tissot JD; Nicoloso de Faveri G; Kovacsovics TJ; Perey L; Schneider P; Zwicky C
    Schweiz Med Wochenschr; 2000 Apr; 130(13):478-84. PubMed ID: 10812643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric experience with autologous peripheral blood progenitor cell transplantation: influence of CD34+ cell dose in engraftment kinetics.
    Diaz MA; Alegre A; Villa M; Granda A; de la Vega A; Ramirez M; Ruano D; Gonzalez A; Merino JM; Madero L
    Bone Marrow Transplant; 1996 Oct; 18(4):699-703. PubMed ID: 8899183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.